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Nonimmune fetal hydrops (NIFH) describes the abnormal
accumulation of ﬂuid in at least two fetal compartments,
including soft tissue edema, or ﬂuid accumulation in body
cavities such as ascites, pleural effusion, or pericardial effusion.
Polyhydramnios and placentomegaly frequently accompany
fetal hydrops. NIFH is a heterogeneous condition and
establishing a diagnosis can be challenging. Bellini et al.1
reviewed and classiﬁed causes of NIFH in order of prevalence:
cardiovascular disorders (21.7%), chromosome imbalances
(13.4%), hematologic abnormalities (10.4%), infections (6.7%),
intrathoracic masses (6.0%), lymph vessel dysplasias (5.7%),
twin-to-twin transfusions and placental causes (5.6%), syndromic
(4.4%), urinary tract malformations (2.3%), inborn errors of
metabolism (1.1%), extra-thoracic tumors (0.7%), gastrointestinal
disorders (0.5%), miscellaneous causes (3.7%), and idiopathic
(17.8%). After excluding immune causes of fetal hydrops, the
search for an underlying cause of NIFH may be extensive and
include ultrasound, fetal echocardiogram, evaluation for
infectious etiologies, and invasive testing for fetal karyotype.
What constitutes appropriate work-up beyond this initial
investigation is controversial, but could include screening for
metabolic conditions, such as lysosomal storage disease (LSD)
via enzyme analysis in cultured cells from amniocytes or
ﬁbroblasts, microarray analysis to detect microdeletions or
duplications, or single gene testing (e.g. Noonan syndrome).
Sequential protocols for investigation of NIFH have been
proposed to optimize diagnosis and avoid cost prohibitive
investigations.1–3 Despite these efforts, such protocols are not
universally practiced. It remains essential to establish diagnostic
algorithms for NIFH, which optimize resources and to deﬁne
appropriate indications for metabolic disease testing. Key to
these efforts is identifying factors that may facilitate a speciﬁc
prenatal diagnosis in these complicated cases resulting in
improved detection rates and allowing providers to better care
for and counsel their patients. We present two cases of NIFH
caused by underlying lysosomal storage disease: galactosialidosis
(case 1) andmucopolysaccharidosis type VII (case 2). The in utero
presentation and the unique ﬁnding of vacuolated lymphocytes in
fetal peritoneal ﬂuid lead to the diagnosis.
Patient 1, a 27 year old G1P0 female, presented to our
institution at 25 2/7weeks gestation due to known NIFH.
Family history was noncontributory/without consanguinity.
Fetal ascites was ﬁrst suspected at 18weeks gestation during
routine fetal survey. Follow-up ultrasound at 19 5/7weeks
revealed fetal ascites and ventricular septal defect. Concurrent
amniocentesis revealed normal male karyotype (46,XY),
normal amniotic ﬂuid alpha-fetoprotein at 1.3MoM, normal
single nucleotide polymorphism microarray analysis, and
negative PCR for parvovirus B19, cytomegalovirus, varicella
zoster virus, herpes simplex virus, and Toxoplasma gondii.
Ultrasound at 25weeks gestation revealed a hydropic fetus
with appropriate biometry, massive ascites, scalp edema, mild
ventriculomegaly, cardiomegaly with a ventricular septal
defect, dilated loops of bowel with dilated rectum,
placentomegaly, and normal Doppler velocimetry in umbilical
and middle cerebral arteries. At 30 1/7weeks of gestation, peak
systolic velocities of the middle cerebral artery were elevated at
1.55MoM. Given this and further progression of fetal hydrops
of unknown etiology, the patient underwent ultrasound guided
cordocentesis with fetal blood transfusion for mild anemia
(hematocrit 30%). A fetal paracentesis was performed to
remove 500 cc of ascites because of concern that the upward
compression of the diaphragm by the ascites contributed to
the worsening hydrops. Review of fetal ascitic ﬂuid revealed
predominantly histiocytes (93%) and rare vacuolated
lymphocytes. Despite initial improvement in hydrops,
reaccumulation occurred. Repeat fetal paracentesis removing
300 cc was undertaken to decompress the abdomen and
facilitate vaginal delivery prior to induction at 36weeks of
gestation (head circumference to abdominal circumference
ratio was 0.73). A 2240 g male infant was delivered with Apgar
scores of 2 and 5 at 1 and 5min. Physical exam revealed poor
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respiratory effort requiring intubation, abdominal wall laxity,
skin edema, and low-set ears. Marked cytoplasmic vacuolization
was seen in lymphocytes in ascites ﬂuid (Figure 1) sent
immediately prior to delivery and within placenta, suggestive
of a metabolic storage disease. Enzyme screening panel for
LSD revealed low beta-galactosidase activity in leukocytes
(8.5nmol/hr/mg protein, approximately 10% of normal) with
normal activity in plasma, and high sialic acid content in
leukocytes with normal free sialic acid content, resulting in
diagnosis of galactosialidosis. The infant was extubated on day
of life 17, discharged to home at 1month of age, and is currently
receiving home hospice services.
Patient 2 is a 33year old G1P0 female whose routine fetal
anatomy scan at 19 1/7weeks of gestation revealed skin edema,
bilateral pleural effusions, and ascites. Family history was
noncontributory/without consanguinity. Amniocentesis revealed
normal male karyotype (46,XY), normal oligonucleotide array,
and negative work-up for cytomegalovirus, parvovirus, and
toxoplasmosis. Patient was referred at 21 6/7weeks of gestation
for second opinion and ultrasound conﬁrmed the prior ﬁndings.
Fetal thoracentesis was performed to evaluate pleural effusions
for lymphocytes and to consider if thoracic shunting would be a
potential therapy for this fetus. The pleural ﬂuid was
predominantly reactive histiocytes; patient continued the
pregnancy without further fetal interventions. Ultrasound at 22
6/7weeks revealed reaccumulation and worsening of pleural
effusions, skin edema, and hydroceles, with normal umbilical
and middle cerebral artery Doppler velocimetries. Subsequent
ultrasounds revealed stable hydrops. At 36weeks of gestation,
abnormal antenatal testing lead to cesarean delivery of a 3740g
male infant with Apgars of 6 and 7 at 1 and 5min. Paracentesis
(620mL removed) was performed prior to delivery to facilitate
resuscitation and ease of delivery. Review of fetal ascites ﬂuid
revealed metachromatic cytoplasmic granules within leukocytes
of all types (Alder–Reilly anomaly, Figure 2), suggestive of
mucopolysaccharidosis (MPS). Placental histopathology showed
marked fetal obliterative vasculopathy with extensive villous
avascularity, vascular myonecrosis, and villous edema. Urine
studies revealed abnormal excretion of mucopolysaccharides.
Enzymatic analysis showed signiﬁcantly reduced beta
glucuronidase activity in leukocytes consistent with a diagnosis
of MPS VII (Sly syndrome). GUSB gene sequencing revealed
heterozygosity for two previously unreported variants (c.148G>T
and c.1824C>G). Both changes are predicted to result in
pathogenic amino acid substitutions. The infant was discharged
home on day of life 40 with nasogastric tube feeds and is followed
by palliative care team.
Nonimmune fetal hydrops is a heterogeneous condition. In
the majority of cases, inborn errors of metabolism will not be
considered until there are multiple affected pregnancies.
Several LSDs have been diagnosed following the presentation
of NIFH. We present two cases of NIFH due to LSD diagnosed
in a ﬁrst pregnancy highlighting the unique circumstances that
led to a diagnosis. In both cases, the ultrasound ﬁndings of
NIFH included marked ascites. Massive ascites has previously
been reported as a key ﬁnding in in utero manifestation of
sialic acid and other LSDs.4 In contrast, cases of Noonan
syndrome are more likely to present with increased nuchal
translucency, cystic hygroma, and hydrothorax.5 A greater
Figure 1 Marked vacuolization of histiocytes and lymphocytes in ascites
derived from fetus with galactosialidosis. Photograph taken at 1000×
magniﬁcation (oil immersion)
Figure 2 Alder–Reilly (chunky deeply asurophilic) bodies and
metachromatic inclusions (arrows) and vacuoles (arrowhead) in
histiocytes and lymphocytes in ascites derived from fetus with MPS
VII. Photograph taken at 1000× magniﬁcation (oil immersion)
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awareness of the presentation of the more rare etiologies for
NIFHmay help guide prenatal testing when the more common
causes have been eliminated. This may be particularly useful
when prenatal samples are limited. Furthermore, the
diagnosis, once made in a family, allows for mutation analysis
and prenatal DNA testing in future pregnancies.
In both of the presented cases, the initial investigation into
the etiology of NIFH was negative, and testing for inborn errors
of metabolism was not included. Fluid samples obtained from
therapeutic procedures in both cases contributed to the early
diagnosis following delivery. Vacuolization in fetal cells of
placentas6 and circulating leukocytes7 has been well
documented in cases of infantile LSD. Vacuolated lymphocytes
were reported in ascites of a newborn delivered at 31 4/7weeks
of gestation.8 To our knowledge, ours are the ﬁrst reported
cases of vacuolization in lymphocytes obtained via fetal
paracentesis. Cytologic evaluation of paracentesis ﬂuid at 30
1/7weeks of gestation (case 1) revealed a low lymphocyte
count (4%) with few vacuolated lymphocytes noted. However,
ascites obtained at 36weeks of gestation contained
signiﬁcantly more lymphocytes (63%) with marked
cytoplasmic vacuolization suggestive of an underlying LSD.
All differentiated blood cell types, including lymphocytes, are
represented in peripheral circulation by 30weeks of gestation;
however, their proportions continue to change throughout
the remainder of pregnancy and the neonatal period.9 Whether
the difference in content of vacuolated lymphocytes in
successive paracentesis ﬂuids reﬂects sampling error or in
utero progression of disease remains unknown, but gestational
age could alter the diagnostic utility of testing the ascitic ﬂuid.
In case 2, cytologic evaluation of fetal ascites obtained at 36 3/
7weeks of gestation revealed Alder–Reilly bodies within
histiocytes and metachromatic granules and vacuoles within
lymphocytes, suggestive of mucopolysaccharidosis. Placental
examination showed marked damage of fetal vasculature. We
are unaware of reports of vacuolization at earlier gestational
ages. In a case report of NIFH associated with MPS VII that
resulted in intrauterine fetal demise at 16weeks, no abnormal
inclusions or vacuolization of blood cells or placenta were
noted.10
In conclusion, we report two cases of NIFH due to lysosomal
storage disease: galactosialidosis and mucopolysaccharidosis
type VII. In both cases, massive ascites was a signiﬁcant ﬁnding
at presentation. Cytologic evaluation of fetal ascites revealed
vacuolated lymphocytes, guiding further testing and
expediting postnatal diagnosis. Histopathologic examination
of fetal ascites may be useful in cases in which paracentesis is
performed for therapeutic reasons, and etiology for the ascites
is unknown. In our cases, abnormal vacuolization was seen in
the third trimester. Second trimester pathology in fetal ascites
may not be as reliable, possibly due to evolution of the storage
disease or natural history of the ascites.
WHAT’S ALREADY KNOWN ABOUT THIS TOPIC?
• Nonimmune fetal hydrops (NIFH) is a heterogeneous condition and
establishing a diagnosis can be challenging.
• Inborn errors of metabolism are one of many possible etiologies
for NIFH.
• Inborn errors of metabolism are often missed in utero.
WHAT DOES THIS STUDY ADD?
• We present two cases of NIFH caused by underlying lysosomal
storage disease: galactosialidosis and mucopolysaccharidosis
type VII.
• The unique ﬁnding of vacuolated lymphocytes in fetal peritoneal
ﬂuid lead to the diagnosis.
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